Who owns ARCT?
Institutional ownership of Arcturus Therapeutics Holdings Inc. from Form 13F, Q2 2026
135 institutional managers reported holding Arcturus Therapeutics Holdings Inc. (ARCT) in Form 13F filings for Q2 2026, with 24,984,285 shares worth $168M. The largest reported holder was Federated Hermes, Inc. Managers that filed both quarters added a net 703,515 shares (+2.9%). 19 opened new positions and 9 sold out.
- Funds holding
- 135
- Value held
- $168M
- New / sold out
- 19 / 9
- Net shares, same filers
- +2.9%
Holdings as of June 30, 2026, the end of Q2 2026. Managers have 45 days after a quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.
Largest holders of ARCT
Share of 13F holdings is each fund's shares as a share of the 24,984,285 ARCT shares all 13F filers reported, not of shares outstanding.
Biggest buyers in Q2 2026
- AQR Capital Management LLC Added+$3.5M
- Jacobs Levy Equity Management, Inc Added+$3.0M
- Point72 Asset Management, L.P. Added+$1.1M
- D. E. Shaw & Co., Inc. Added+$943K
- ARK Investment Management LLC Added+$888K
- Goldman Sachs Group Inc Added+$747K
- Marshall Wace, LLP New+$519K
- Jump Financial, LLC Added+$470K
- BNP Paribas Financial Markets Added+$450K
- Hennion & Walsh Asset Management, Inc. Added+$447K
Biggest sellers in Q2 2026
- Amova Asset Management Americas, Inc. Trimmed-$2.2M
- Sumitomo Mitsui Trust Group, Inc. Trimmed-$2.2M
- Renaissance Technologies LLC Trimmed-$1.1M
- Susquehanna International Group, LLP Trimmed-$1.1M
- Acadian Asset Management LLC Trimmed-$998K
- Millennium Management LLC Trimmed-$951K
- Gsa Capital Partners LLP Trimmed-$568K
- Dimensional Fund Advisors LP Trimmed-$451K
- Susquehanna Portfolio Strategies, LLC Trimmed-$327K
- Heartland Advisors Inc Trimmed-$247K
The change in shares since the quarter before, adjusted for stock splits and priced at the Q2 2026 value per share. Funds bought $16.9M and sold $12.2M; 55 added and 40 trimmed.
Schedule 13D and 13G filings on ARCT
Owners of more than 5% must file within days, so these can be newer than the 13F data.
- 2026-11-18Meiji Seika Pharma Co., Ltd. SCHEDULE 13G filed by Arcturus Therapeutics Holdings Inc.Schedule 13G
- 2025-11-14BALYASNY ASSET MANAGEMENT L.P. SCHEDULE 13G filed by Arcturus Therapeutics Holdings Inc.Schedule 13G
- 2025-02-05STATE STREET CORP SCHEDULE 13G filed by Arcturus Therapeutics Holdings Inc.Schedule 13G
Questions about ARCT ownership
- Who owns ARCT stock?
- 135 institutional investment managers reported ARCT positions in their Form 13F filings for Q2 2026, holding 24,984,285 shares worth $168M in total. Federated Hermes, Inc. reported the largest position.
- Are funds buying or selling ARCT?
- In Q2 2026, 19 managers opened new ARCT positions, 55 added, 40 trimmed and 9 sold out. Managers that filed in both quarters added a net 703,515 shares.
- How current is this ARCT institutional ownership data?
- It covers holdings as of the end of Q2 2026. Managers have 45 days after the quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.
From the SEC's Form 13F data sets for Q2 2026: every 13F holdings report, matched to ARCT by CUSIP. Options are left out. ARCT news and filings · ARCT insider trades · Top funds